These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 14968435)

  • 1. Separation of enzymatically active and inactive prostate-specific antigen (PSA) by peptide affinity chromatography.
    Wu P; Stenman UH; Pakkala M; Närvänen A; Leinonen J
    Prostate; 2004 Mar; 58(4):345-53. PubMed ID: 14968435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategy for sensitive and specific detection of molecular forms of PSA based on 2DE and kinetic analysis: a step towards diagnosis of prostate cancer.
    Kumar V; Hassan MI; Singh AK; Dey S; Singh TP; Yadav S
    Clin Chim Acta; 2009 May; 403(1-2):17-22. PubMed ID: 19118539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentration of enzymatically active prostate-specific antigen (PSA) in the extracellular fluid of primary human prostate cancers and human prostate cancer xenograft models.
    Denmeade SR; Sokoll LJ; Chan DW; Khan SR; Isaacs JT
    Prostate; 2001 Jun; 48(1):1-6. PubMed ID: 11391681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective recognition of enzymatically active prostate-specific antigen (PSA) by anti-PSA monoclonal antibodies.
    Michel S; Collomb-Clerc E; Geourjon C; Charrier JP; Passagot J; Courty Y; Deléage G; Jolivet-Reynaud C
    J Mol Recognit; 2005; 18(3):225-35. PubMed ID: 15593306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: a glycopeptide approach.
    Tajiri M; Ohyama C; Wada Y
    Glycobiology; 2008 Jan; 18(1):2-8. PubMed ID: 17956937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of novel peptide ligands modulating the enzyme activity of prostate-specific antigen.
    Leinonen J; Wu P; Koivunen E; Närvänen A; Stenman UH
    Scand J Clin Lab Invest Suppl; 2000; 233():59-64. PubMed ID: 11317943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural characterization and anti-angiogenic properties of prostate-specific antigen isoforms in seminal fluid.
    Mattsson JM; Valmu L; Laakkonen P; Stenman UH; Koistinen H
    Prostate; 2008 Jun; 68(9):945-54. PubMed ID: 18386289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy.
    Ohyama C; Hosono M; Nitta K; Oh-eda M; Yoshikawa K; Habuchi T; Arai Y; Fukuda M
    Glycobiology; 2004 Aug; 14(8):671-9. PubMed ID: 15044396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha1,2-Fucosylated and beta-N-acetylgalactosaminylated prostate-specific antigen as an efficient marker of prostatic cancer.
    Fukushima K; Satoh T; Baba S; Yamashita K
    Glycobiology; 2010 Jan; 20(4):452-60. PubMed ID: 20008118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sensitive proximity ligation assay for active PSA.
    Zhu L; Koistinen H; Wu P; Närvänen A; Schallmeiner E; Fredriksson S; Landegren U; Stenman UH
    Biol Chem; 2006 Jun; 387(6):769-72. PubMed ID: 16800738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA.
    Tabarés G; Radcliffe CM; Barrabés S; Ramírez M; Aleixandre RN; Hoesel W; Dwek RA; Rudd PM; Peracaula R; de Llorens R
    Glycobiology; 2006 Feb; 16(2):132-45. PubMed ID: 16177264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two step procedure for purification of enzymatically active prostate-specific antigen from seminal plasma.
    Bindukumar B; Kawinski E; Cherrin C; Gambino LM; Nair MP; Schwartz SA; Chadha KC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 813(1-2):113-20. PubMed ID: 15556523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen (PSA) protein does not affect growth of prostate cancer cells in vitro or prostate cancer xenografts in vivo.
    Denmeade SR; Litvinov I; Sokoll LJ; Lilja H; Isaacs JT
    Prostate; 2003 Jun; 56(1):45-53. PubMed ID: 12746846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-associated forms of prostate specific antigen improve the discrimination of prostate cancer from benign disease.
    Mikolajczyk SD; Rittenhouse HG
    Rinsho Byori; 2004 Mar; 52(3):223-30. PubMed ID: 15137320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A precursor form of PSA (pPSA) is a component of the free PSA in prostate cancer serum.
    Mikolajczyk SD; Grauer LS; Millar LS; Hill TM; Kumar A; Rittenhouse HG; Wolfert RL; Saedi MS
    Urology; 1997 Nov; 50(5):710-4. PubMed ID: 9372880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of prostate-specific antigen binding peptides selected by phage display technology.
    Ferrieu-Weisbuch C; Michel S; Collomb-Clerc E; Pothion C; Deléage G; Jolivet-Reynaud C
    J Mol Recognit; 2006; 19(1):10-20. PubMed ID: 16312021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and processing of prostate specific antigen (hK3) and human glandular kallikrein (hK2) secreted by LNCaP cells.
    Väisänen V; Lövgren J; Hellman J; Piironen T; Lilja H; Pettersson K
    Prostate Cancer Prostatic Dis; 1999 Mar; 2(2):91-97. PubMed ID: 12496845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic activation of a doxorubicin-peptide prodrug by prostate-specific antigen.
    Denmeade SR; Nagy A; Gao J; Lilja H; Schally AV; Isaacs JT
    Cancer Res; 1998 Jun; 58(12):2537-40. PubMed ID: 9635575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and purification of recombinant active prostate-specific antigen from Escherichia coli.
    Jeong S; Lee SW
    J Microbiol Biotechnol; 2007 May; 17(5):840-6. PubMed ID: 18051307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fast and novel purification method to obtain the prostate specific antigen (PSA) from human seminal plasma.
    Acevedo B; Perera Y; Torres E; Pentón D; Ayala M; Gavilondo J
    Prostate; 2006 Jul; 66(10):1029-36. PubMed ID: 16598740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.